201 related articles for article (PubMed ID: 22746213)
1. Prodromal metabolic phenotype in MCI cybrids: implications for Alzheimer's disease.
Silva DF; Santana I; Esteves AR; Baldeiras I; Arduino DM; Oliveira CR; Cardoso SM
Curr Alzheimer Res; 2013 Feb; 10(2):180-90. PubMed ID: 22746213
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity.
Cardoso SM; Santana I; Swerdlow RH; Oliveira CR
J Neurochem; 2004 Jun; 89(6):1417-26. PubMed ID: 15189344
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial-dependent apoptosis in Huntington's disease human cybrids.
Ferreira IL; Nascimento MV; Ribeiro M; Almeida S; Cardoso SM; Grazina M; Pratas J; Santos MJ; Januário C; Oliveira CR; Rego AC
Exp Neurol; 2010 Apr; 222(2):243-55. PubMed ID: 20079354
[TBL] [Abstract][Full Text] [Related]
4. Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines.
Silva DF; Selfridge JE; Lu J; E L; Roy N; Hutfles L; Burns JM; Michaelis EK; Yan S; Cardoso SM; Swerdlow RH
Hum Mol Genet; 2013 Oct; 22(19):3931-46. PubMed ID: 23740939
[TBL] [Abstract][Full Text] [Related]
5. Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease.
Sheehan JP; Swerdlow RH; Miller SW; Davis RE; Parks JK; Parker WD; Tuttle JB
J Neurosci; 1997 Jun; 17(12):4612-22. PubMed ID: 9169522
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial function in Parkinson's disease cybrids containing an nt2 neuron-like nuclear background.
Esteves AR; Domingues AF; Ferreira IL; Januário C; Swerdlow RH; Oliveira CR; Cardoso SM
Mitochondrion; 2008 Jun; 8(3):219-28. PubMed ID: 18495557
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
Yu Q; Du F; Douglas JT; Yu H; Yan SS; Yan SF
J Alzheimers Dis; 2017; 59(1):223-239. PubMed ID: 28598851
[TBL] [Abstract][Full Text] [Related]
8. Cybrids in Alzheimer's disease: a cellular model of the disease?
Swerdlow RH; Parks JK; Cassarino DS; Maguire DJ; Maguire RS; Bennett JP; Davis RE; Parker WD
Neurology; 1997 Oct; 49(4):918-25. PubMed ID: 9339668
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture.
Trimmer PA; Keeney PM; Borland MK; Simon FA; Almeida J; Swerdlow RH; Parks JP; Parker WD; Bennett JP
Neurobiol Dis; 2004 Feb; 15(1):29-39. PubMed ID: 14751768
[TBL] [Abstract][Full Text] [Related]
10. Amyloid β-induced ER stress is enhanced under mitochondrial dysfunction conditions.
Costa RO; Ferreiro E; Martins I; Santana I; Cardoso SM; Oliveira CR; Pereira CM
Neurobiol Aging; 2012 Apr; 33(4):824.e5-16. PubMed ID: 21704433
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Alterations in Peripheral Mononuclear Blood Cells from Alzheimer's Disease and Mild Cognitive Impairment Patients.
Delbarba A; Abate G; Prandelli C; Marziano M; Buizza L; Arce Varas N; Novelli A; Cuetos F; Martinez C; Lanni C; Memo M; Uberti D
Oxid Med Cell Longev; 2016; 2016():5923938. PubMed ID: 26881032
[TBL] [Abstract][Full Text] [Related]
12. Platelet Proteomic Analysis Revealed Differential Pattern of Cytoskeletal- and Immune-Related Proteins at Early Stages of Alzheimer's Disease.
González-Sánchez M; Díaz T; Pascual C; Antequera D; Herrero-San Martín A; Llamas-Velasco S; Villarejo-Galende A; Bartolome F; Carro E
Mol Neurobiol; 2018 Dec; 55(12):8815-8825. PubMed ID: 29603091
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin A increases resting mitochondrial membrane potential in SY5Y cells and reverses the depressed mitochondrial membrane potential of Alzheimer's disease cybrids.
Cassarino DS; Swerdlow RH; Parks JK; Parker WD; Bennett JP
Biochem Biophys Res Commun; 1998 Jul; 248(1):168-73. PubMed ID: 9675105
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
[TBL] [Abstract][Full Text] [Related]
15. Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer's disease and mild cognitive impairment.
Mangialasche F; Baglioni M; Cecchetti R; Kivipelto M; Ruggiero C; Piobbico D; Kussmaul L; Monastero R; Brancorsini S; Mecocci P
J Alzheimers Dis; 2015; 44(2):649-60. PubMed ID: 25322927
[TBL] [Abstract][Full Text] [Related]
16. Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease.
Ghosh SS; Swerdlow RH; Miller SW; Sheeman B; Parker WD; Davis RE
Ann N Y Acad Sci; 1999; 893():176-91. PubMed ID: 10672237
[TBL] [Abstract][Full Text] [Related]
17. Effects of ageing and Alzheimer's disease on mitochondrial function of human platelets.
Shi C; Guo K; Yew DT; Yao Z; Forster EL; Wang H; Xu J
Exp Gerontol; 2008 Jun; 43(6):589-94. PubMed ID: 18359596
[TBL] [Abstract][Full Text] [Related]
18. Increased apoptosis in the platelets of patients with Alzheimer's disease and amnestic mild cognitive impairment.
Zhao S; Zhao J; Zhang T; Guo C
Clin Neurol Neurosurg; 2016 Apr; 143():46-50. PubMed ID: 26895209
[TBL] [Abstract][Full Text] [Related]
19. Characterizing Aging, Mild Cognitive Impairment, and Dementia with Blood-Based Biomarkers and Neuropsychology.
Kleinschmidt M; Schoenfeld R; Göttlich C; Bittner D; Metzner JE; Leplow B; Demuth HU
J Alzheimers Dis; 2016; 50(1):111-26. PubMed ID: 26639953
[TBL] [Abstract][Full Text] [Related]
20. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines.
Trimmer PA; Swerdlow RH; Parks JK; Keeney P; Bennett JP; Miller SW; Davis RE; Parker WD
Exp Neurol; 2000 Mar; 162(1):37-50. PubMed ID: 10716887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
